Saw Palmetto: Clinical Evidence & Substantiation Summary

Clinical Trials
34
Strongest Evidence
Prostate Health
Typical Dosage
320 mg/day (lipophilic extract)
Common Forms
Lipophilic berry extract

What Is Saw Palmetto?

Saw palmetto (Serenoa repens) is a palm plant extract widely used for prostate and urinary health support. It is one of the most studied botanicals for men's health, with evidence primarily supporting urinary symptom management.

Mechanism of action: Saw palmetto inhibits both isoforms of 5-alpha-reductase, reducing conversion of testosterone to dihydrotestosterone (DHT). It also exhibits anti-inflammatory effects via inhibition of COX-2 and 5-LOX pathways, and has anti-proliferative effects on prostatic tissue.

Clinical Evidence Summary

Below are 5 key clinical studies on Saw Palmetto. Nutra Comp analyses 34+ studies in its full clinical evidence report.

Cochrane systematic review2019PMID: 30547890

Saw palmetto for benign prostatic hyperplasia: updated Cochrane review

Population: 27 RCTs, 5,222 men

Key finding: Saw palmetto (320 mg lipophilic extract) showed modest improvements in urinary symptom scores (IPSS), though results were mixed across studies.

Meta-analysis2018PMID: 29610056

Saw palmetto and lower urinary tract symptoms: meta-analysis

Population: 12 RCTs

Key finding: Saw palmetto significantly improved peak urinary flow rate (WMD: 1.02 mL/s, p=0.03) and nocturia frequency.

Review2019PMID: 31433477

Saw palmetto extract and DHT: mechanism review

Population: Clinical and preclinical studies

Key finding: Saw palmetto inhibited 5-alpha-reductase activity in human prostate tissue and reduced serum DHT levels in clinical studies.

Systematic review2021PMID: 32540634

Safety of long-term saw palmetto supplementation

Population: 15 studies (1–3 years)

Key finding: Long-term saw palmetto use maintained a favourable safety profile with side effect rates comparable to placebo.

Combination phytotherapy for prostate health

Population: 225 men

Key finding: Saw palmetto combined with lycopene and selenium showed additive benefits for urinary symptoms vs. saw palmetto alone (p=0.03).

Evidence-Based Structure–Function Claims

Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.

8
Supports healthy prostate function
Category: Prostate Health · Confidence: 8/10
7
Supports healthy urinary flow and frequency
Category: Urinary Health · Confidence: 7/10
7
Supports healthy DHT metabolism
Category: Hormonal Health · Confidence: 7/10

Get the full substantiation report for Saw Palmetto

Includes all 34+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.

Join Waitlist for Full Access

Related Ingredients

Zinc
92 studies · Immune Function
Selenium
64 studies · Thyroid Function

Key Terms

Randomised Controlled Trial (RCT)Standardised ExtractClinically Effective Dose

Frequently Asked Questions

Is saw palmetto FDA approved?

Saw palmetto is sold as a dietary supplement in the US and does not require FDA approval. In Europe, standardised extracts (e.g., Permixon) are approved as herbal medicines.

What are the most studied benefits?

The strongest evidence supports saw palmetto for prostate health, urinary symptom management, and DHT modulation.

What dosage is used?

The standard dose is 320 mg/day of a lipophilic (fat-soluble) extract, standardised to 85–95% fatty acids and sterols.

Stop Spending Weeks on Substantiation

Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.

Join the Waitlist